{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:51:36Z","timestamp":1785466296417,"version":"3.56.0"},"reference-count":40,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2008,10,10]],"date-time":"2008-10-10T00:00:00Z","timestamp":1223596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2008,11]]},"abstract":"<jats:p><jats:bold>Background:\u2002<\/jats:bold>We previously reported that a<jats:italic>Lactobacillus acidophilus<\/jats:italic>probiotic strain (LAFTI<jats:sup>\u00ae<\/jats:sup>L10\/LAVRI\u2010A1) given for the first 6\u2003months of life increased the risk of allergen sensitization at 1\u2003year of age.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold>To assess the effects on subsequent allergic outcomes, 153 children from the initial prevention cohort (<jats:italic>n<\/jats:italic>\u2003=\u2003178) were reviewed at 2.5\u2003years of age. Clinical outcomes were assessed in relation to (i) probiotic supplementation; and (ii) immune function previously assessed at 6\u2003months of age.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold>Supplementation with this probiotic did not reduce the risk of dermatitis at 2.5\u2003years (31\/74, 42%) compared with that in placebo group (25\/76, 34%). There was no significant reduction in any other allergic disease or allergen sensitization. Inhalant sensitization at 2.5\u2003years (<jats:italic>n<\/jats:italic>\u2003=\u200329) was associated with higher proportions of circulating CD4+ CD25+ regulatory T\u2010cell populations (<jats:italic>P<\/jats:italic>\u2003=\u20030.005) and higher allergen\u2010induced FOXP3 levels (<jats:italic>P<\/jats:italic>\u2003=\u20030.003) at 6\u2003months. This was also seen in children with dermatitis. Children with dermatitis at 2.5\u2003years also had significantly lower toll\u2010like receptor 4 lipopolysaccharide responses at 6\u2003months of age (IL\u201012<jats:italic>P<\/jats:italic>\u2003=\u20030.04, IL\u20106<jats:italic>P<\/jats:italic>\u2003=\u20030.039) and lower polyclonal (PHA) responses (IFN\u2010\u03b3<jats:italic>P<\/jats:italic>\u2003=\u20030.005, IL\u201010<jats:italic>P<\/jats:italic>\u2003=\u20030.001, and IL\u20106<jats:italic>P<\/jats:italic>\u2003=\u20030.001). Children who had previously received the probiotic had fewer gastrointestinal infections in the preceding 18\u2003months (<jats:italic>P<\/jats:italic>\u2003=\u20030.023).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold>The LAFTI<jats:sup>\u00ae<\/jats:sup>L10 probiotic strain did not have any significant effect on allergy outcomes. Allergic children showed a number of early differences in immune function including altered regulatory T\u2010cell markers and innate immune function.<\/jats:p>","DOI":"10.1111\/j.1398-9995.2008.01778.x","type":"journal-article","created":{"date-parts":[[2008,10,11]],"date-time":"2008-10-11T17:05:52Z","timestamp":1223744752000},"page":"1481-1490","source":"Crossref","is-referenced-by-count":72,"title":["Early markers of allergic disease in a primary prevention study using probiotics: 2.5\u2010year follow\u2010up phase"],"prefix":"10.1111","volume":"63","author":[{"given":"S. L.","family":"Prescott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wiltschut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Westcott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Dunstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,10,10]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.04.027"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.2000.00943.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70093-9"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2004.00514.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2003.389"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.060673"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04259-8"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.09.009"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.01.007"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.08.036"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.2005.024364"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijfoodmicro.2006.10.007"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2005.02811.x"},{"key":"e_1_2_6_15_2","volume-title":"Joint FAO\/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including milk powder with live lactic acid bacteria","year":"2001"},{"key":"e_1_2_6_16_2","volume-title":"Joint FAO\/WHO working group guidelines for the evaluation of probiotics in food","year":"2002"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.12.591"},{"issue":"144","key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifen J","year":"1980","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247298"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.09.009"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.02.014"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1006\/abio.2001.5369"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2006.02552.x"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3038.2006.00483.x"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2006.02553.x"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91641-1"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1994.tb00930.x"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(95)70264-4"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1998.00418.x"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)05104-6"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2222.1998.028s5039.x"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(03)01868-2"},{"key":"e_1_2_6_33_2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2222.2007.02856.x","article-title":"The relationship between early intestinal colonisation, mucosal IgA production and systemic immune development","volume":"38","author":"Martino DJ","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13490-3"},{"key":"e_1_2_6_35_2","first-page":"992","article-title":"A differential effect of two probiotics in the prevention of eczema and atopy","volume":"316","author":"Wickens K","year":"2007","journal-title":"World Allergy Organization Journal"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.03.036"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.03.047"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2005.02376.x"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.12.1307"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020057"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e3181568105"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2008.01778.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.2008.01778.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T15:09:09Z","timestamp":1709305749000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2008.01778.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,10]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["10.1111\/j.1398-9995.2008.01778.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01778.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,10]]}}}